Invesco Ltd. Amphastar Pharmaceuticals, Inc. Transaction History
Invesco Ltd.
- $557 Billion
- Q2 2025
A detailed history of Invesco Ltd. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 386,971 shares of AMPH stock, worth $11.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
386,971
Previous 359,143
7.75%
Holding current value
$11.7 Million
Previous $10.4 Million
14.67%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding AMPH
# of Institutions
256Shares Held
33.3MCall Options Held
18.3KPut Options Held
12.6K-
Black Rock Inc. New York, NY5.94MShares$180 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$81.5 Million0.0% of portfolio
-
Td Asset Management Inc2.03MShares$61.8 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.63MShares$49.4 Million0.01% of portfolio
-
State Street Corp Boston, MA1.58MShares$47.8 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.49B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...